First Venture Sweden (”First Venture” eller ”Bolaget”) är ett investmentbolag med fokus på snabbväxa...
Redeye shares its initial take on TH1NG’s Q3 report, in which revenues were in line with our modest ...
Redeye briefly comments on the positive news that Saniona has outlicensed SAN711 to Acadia in neurol...
Redeye comments on Maximum Entertainment’s Q3-results which were weaker than expected.
Ramlösa Shipping publicerade den 26 november år 2024 bolagets delårsrapport för det tredje kvartalet...
Redeye shares its key takeaways and nuggets from Devyser’s Capital Markets Day.
De diskussioner som Eastnine bekräftade i början av november har idag mynnat ut i ett jätteförvärv a...
Today Absolent announced that Anders Hülse has been appointed new CEO and President of the group.
AcuCort (”AcuCort” eller ”Bolaget”) meddelade den 26 november år 2024 att Bolaget nyligen har presen...
Redeye comments on Freemelt’s agreement with another leading global orthopedic implant OEM.
Redeye returns following Kancera’s strategic shift to focus on cardiovascular diseases and its Q3 re...
Redeye provides a preview for Integrum’s Q2 report, due on Wednesday, December 4.
Kinda Brave har publicerat koncernens delårsrapport för det tredje kvartalet år 2024 och visar på fo...
ODI Pharma published on November 22nd the company’s Q1-report for 2024/2025.
Analyst Group har med Titania ingått avtal om kontinuerlig analysbevakning, innefattande bl.
Embark Group har publicerat bolagets delårsrapport för det tredje kvartalet år 2024, som visade en s...
The Duell AGM was held on November 20, 2024, where a decision was passed regarding the reverse split...
Redeye briefly comments on Arise’s press release from earlier this week related to the settlement ag...
Q3 weaker, but entering Q4 with better momentum EBIT estimates cut by 3% on '25e-'26e Share is tradi...
EcoRub (”EcoRub” eller ”Bolaget”) levererar unika material där affärsidén är att förädla återvunnen ...
